Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1984 1
1986 2
1987 1
1990 1
1991 2
1992 2
1993 2
1994 1
1995 1
1997 3
1998 4
1999 4
2000 3
2001 2
2002 4
2003 5
2004 4
2005 2
2006 3
2007 6
2008 9
2009 3
2010 7
2011 7
2012 8
2013 7
2014 5
2015 6
2016 2
2017 3
2018 5
2019 4
2020 9
2021 10
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Myeloid Sarcoma in Remission"
Page 1
Myeloid sarcoma: more and less than a distinct entity.
Loscocco GG, Vannucchi AM. Loscocco GG, et al. Ann Hematol. 2023 Aug;102(8):1973-1984. doi: 10.1007/s00277-023-05288-1. Epub 2023 Jun 7. Ann Hematol. 2023. PMID: 37286874 Free PMC article. Review.
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour mass of myeloid blasts occurring at an anatomical site other than the bone marrow, in most cases concomitant with acute myeloid leukaemia (AML), rarely without …
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour mass of myeloid blasts occ …
Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved.
Shallis RM, Gale RP, Lazarus HM, Roberts KB, Xu ML, Seropian SE, Gore SD, Podoltsev NA. Shallis RM, et al. Blood Rev. 2021 May;47:100773. doi: 10.1016/j.blre.2020.100773. Epub 2020 Oct 30. Blood Rev. 2021. PMID: 33213985 Review.
The World Health Organization classification and definition of "myeloid sarcoma" is imprecise and misleading. A more accurate term is "extramedullary acute myeloid leukemia tumor (eAML)." ...About 75-90% of patients with isolated eAML will develop metachronou …
The World Health Organization classification and definition of "myeloid sarcoma" is imprecise and misleading. A more accurate …
Myeloid sarcoma.
Shahin OA, Ravandi F. Shahin OA, et al. Curr Opin Hematol. 2020 Mar;27(2):88-94. doi: 10.1097/MOH.0000000000000571. Curr Opin Hematol. 2020. PMID: 31904666 Review.
The significance of cytogenetic and molecular abnormalities in myeloid sarcoma is not completely established, but testing for targetable mutations on myeloid sarcoma cells is feasible, imperative, and may guide treatment decisions. Outcomes in myelo …
The significance of cytogenetic and molecular abnormalities in myeloid sarcoma is not completely established, but testing for …
Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21).
Hu G, Lu A, Wu J, Jia Y, Zuo Y, Ding M, Zhang L. Hu G, et al. Pediatr Hematol Oncol. 2021 Feb;38(1):14-24. doi: 10.1080/08880018.2020.1803462. Epub 2020 Aug 17. Pediatr Hematol Oncol. 2021. PMID: 32803999
The prognosis of myeloid sarcoma (MS) is controversial. Many reports indicated that orbital-MS has a good prognosis and is closely related to t(8;21), but the prognostic role of MS in pediatric t(8;21) AML is unclear. ...Males were more likely t …
The prognosis of myeloid sarcoma (MS) is controversial. Many reports indicated that orbital-MS has a good prognosis …
CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies.
Hu Y, Caldwell KJ, Onciu M, Federico SM, Salek M, Lewis S, Lei S, Zhang J, Nichols KE, Takemoto CM, Triplett BM, Farrar JE, Rubnitz JE, Ribeiro RC, Wlodarski MW. Hu Y, et al. Blood Adv. 2022 Jan 25;6(2):521-527. doi: 10.1182/bloodadvances.2021006139. Blood Adv. 2022. PMID: 34710216 Free PMC article.
Secondary myelodysplastic syndromes and acute myeloid leukemia (sMDS/AML) are rare in children and adolescents and have a dismal prognosis. ...The median age at diagnosis of myeloid malignancy was 17 years (range, 13-23 years). Patients received 1 to 3 cycles …
Secondary myelodysplastic syndromes and acute myeloid leukemia (sMDS/AML) are rare in children and adolescents and have a dismal p …
Characteristics and transplant outcome of myeloid sarcoma: a single-institute study.
Shan M, Lu Y, Yang M, Wang P, Lu S, Zhang L, Qiu H, Chen S, Xu Y, Zhang X, Wu D. Shan M, et al. Int J Hematol. 2021 May;113(5):682-692. doi: 10.1007/s12185-021-03081-2. Epub 2021 Jan 28. Int J Hematol. 2021. PMID: 33511548
We performed a retrospective study describing the characteristics of myeloid sarcoma (MS) and evaluated the outcome of hematopoietic stem cell transplantation (HSCT) in patients with MS. ...Extramedullary disease without complete remission (CR) after inductio …
We performed a retrospective study describing the characteristics of myeloid sarcoma (MS) and evaluated the outcome of hematop …
8p11 myeloproliferative syndrome: a review.
Jackson CC, Medeiros LJ, Miranda RN. Jackson CC, et al. Hum Pathol. 2010 Apr;41(4):461-76. doi: 10.1016/j.humpath.2009.11.003. Hum Pathol. 2010. PMID: 20226962 Review.
Lymph node biopsy in these patients has commonly shown lymphoblastic leukemia/lymphoma, most often reported as being of T-cell lineage, but bilineal myeloid/T-cell lymphomas and less often a myeloid sarcoma are also reported. ...The prognosis is poor d …
Lymph node biopsy in these patients has commonly shown lymphoblastic leukemia/lymphoma, most often reported as being of T-cell lineage, but …
Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature.
Denier M, Tick S, Dubois R, Dulery R, Eller AW, Suarez F, Burroni B, Maurage CA, Bories C, Konopacki J, Puech M, Bouscary D, Cantalloube A, Héron E, Marçais A, Habas C, Theillac V, Keilani C, Bonhomme GR, Gallagher DS, Boumendil J, Abarah W, Sedira N, Bertin S, Choquet S, Sahel JA, Merabet L, Brignole-Baudouin F, Putterman M, Errera MH. Denier M, et al. Medicina (Kaunas). 2022 Mar 21;58(3):456. doi: 10.3390/medicina58030456. Medicina (Kaunas). 2022. PMID: 35334633 Free PMC article. Review.
Background and Objectives: Secondary ocular localizations of hematological malignancies are blinding conditions with a poor prognosis, and often result in a delay in the diagnosis. Materials and Methods: We describe a series of rare cases of ocular involvement in six patie …
Background and Objectives: Secondary ocular localizations of hematological malignancies are blinding conditions with a poor prognosis …
Is acute myeloid leukemia a liquid tumor?
Ohanian M, Faderl S, Ravandi F, Pemmaraju N, Garcia-Manero G, Cortes J, Estrov Z. Ohanian M, et al. Int J Cancer. 2013 Aug 1;133(3):534-43. doi: 10.1002/ijc.28012. Epub 2013 Feb 4. Int J Cancer. 2013. PMID: 23280377 Free PMC article. Review.
Extramedullary manifestations of acute myeloid leukemia (AML) were described as early as the 19th century. ...EML precedes or accompanies development of AML and occurs during or following treatment, even during remission. Although imaging studies are rarely conducte …
Extramedullary manifestations of acute myeloid leukemia (AML) were described as early as the 19th century. ...EML precedes or accompa …
Intracerebral granulocytic sarcoma.
Alvarez M. Alvarez M. J Neurosci Nurs. 2007 Oct;39(5):297-304. doi: 10.1097/01376517-200710000-00007. J Neurosci Nurs. 2007. PMID: 17966297
Granulocytic sarcomas, also known as chloromas, are rare extramedullary tumors of myeloid or myelocytic origin. They are usually associated with both acute and chronic myelogenous leukemia and myeloproliferative disorders. Leukemia involvement of the central nervous system …
Granulocytic sarcomas, also known as chloromas, are rare extramedullary tumors of myeloid or myelocytic origin. They are usually asso …
133 results